ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02849145
Recruitment Status : Active, not recruiting
First Posted : July 29, 2016
Last Update Posted : April 19, 2018
Sponsor:
Information provided by (Responsible Party):
Institut Curie

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 2019
  Estimated Study Completion Date : October 2021